The present invention also disclose certain new salts of Solifenacin as well as well as new polymorphic forms of Solifenacin hydrochloride and Solifenacin oxalate, in pure form.
A crystalline salt of solifenacin hydrogen tartrate.
Provided are new intermediates of solifenacin and methods for their preparation, as well as methods of preparing solifenacin and solifenacin succinate.
These polymorphic forms are particularly useful for preparing solifenacin salts.
Certain compositions and formulations contain a stable amorphous form of solifenacin succinate.
Each light pink, round, film-coated tablet debossed with logo "151" contains 10 mg of solifenacin succinate (equivalent to 7.5 mg of solifenacin).
There is further provided a process for easily producing this composition comprising solifenacin succinate.
Blurred vision: Solifenacin may cause blurred vision.
Each light yellow, round, film-coated tablet debossed with logo "150" contains 5 mg of solifenacin succinate (equivalent to 3.8 mg of solifenacin).
Gastrointestinal disorders: Solifenacin can slow movement through the gastrointestinal tract.
The 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline tartrate is particularly useful for preparing solifenacin succinate.
Polymorphic forms of solifenacin base have been prepared and characterized.
The present invention provides an improved synthetic strategy for the preparation of solifenacin and pharmaceutically acceptable salts thereof.
The active ingredient in VESICARE is solifenacin succinate.
The pharmacokinetics of solifenacin is not significantly influenced by gender.
This invention provides improved methods for making solifenacin and pharmaceutically acceptable salts thereof.
The present invention also provides for a composition comprising of a salt of Solifenacin having at least 98 % purity.
The treatment is an anticholinergic, and contains an active ingredient called solifenacin succinate.
The present invention provides improved processes for preparing chemically and chirally pure Solifenacin base.
Resulting solifenacin in the free base form is converted into the corresponding succinic acid salt using methods known in the art.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод